Global RNA Therapeutics Market

reogma|Global RNA Therapeutics Market

The market size of global RNA therapeutics market is valued at USD 1.2 billion in the year 2020. It is expected to grow at the CAGR of 28.4% within the forecasted time horizon of 2020-2025 because of growing prevalence of chronic diseases & viral infections, rise in development of the mRNA-based vaccines, high target affinity of RNA therapeutics and rising investment in RNA therapeutics.

However, safety issues associated with the use of the RNA therapy and the high cost of the RNA therapeutics might restrain the growth and development of this market. Its market value will reach USD 4.12 billion by the year 2025.

  • Definition / Scope
  • Market Overview
  • Market Risks
  • Top Market Opportunities
  • Market Drivers
  • Market Restraints
  • Industry Challenges
  • Technology Trends
  • Pricing Trends
  • Regulatory Trends
  • Market Size and Forecast
  • Market Outlook
  • Distribution Chain Analysis
  • Competitive Landscape
  • Competitive Factors
  • Key Market Players
  • Strategic Conclusion
  • References
  • Appendix

Definition / Scope

RNA is the versatile molecule with a capacity to regulate gene expression and is relatively easy to manufacture and can act on undruggable targets. RNA therapeutics is the field of next-generation biological drugs concerned with delivering functional RNA at a target. This type of therapeutics is of fragile nature and large in size. The new concepts applicable in this sector are small activating RNA, self-amplifying RNA, mRNA-based expression of Cas 9 gene editing tool and monoclonal antibodies.

The major benefits of this therapeutics are effective delivery of RNA molecules to targeted cells, activation of RNA molecules and specificity without stimulating immune response. This RNA therapeutics market is concerned with the sale of the antisense and RNA interference therapeutics products and related services.

Based on technology, the global RNA therapeutics market is comprised of RNA interference and Antisense RNA.

As per the application of the global RNA therapeutics market is considered, the global RNA therapeutics market consists of oncology, cardiovascular, respiratory disorders, renal disease, neurodegenerative disorders, genetic disorders, infectious diseases and others.

Based on the route of administration, the global RNA therapeutics market is comprised of pulmonary delivery, intravenous injections, intradermal injections, intraperitoneal injections, topical delivery, and others.

reogma|Global RNA Therapeutics Market


This report is 13 mins read | Subscribe now to read further.

Access all reports on site for only US$9.99/mo


Leave a Reply

Next Post

Post COVID Recovery in Thailand’s Cybersecurity Market

Sat Sep 18 , 2021
The market size of global RNA therapeutics market is valued at USD 1.2 billion in the year 2020. It is expected to grow at the CAGR of 28.4% within the forecasted time horizon of 2020-2025 because of growing prevalence of chronic diseases & viral infections, rise in development of the […]
reogma|Global RNA Therapeutics Marketreogma|Global RNA Therapeutics Market

Tags

Tags

Newsletter Signup

Subscribe to our newsletter below and never miss the latest product or an exclusive offer.